COVID-19 reinfection: the role of natural immunity, vaccines, and variants

COVID-19 reinfection: the role of natural immunity, vaccines, and variants

Blog Article

The COVID-19 pandemic has altered innumerable lives.Although recent mass vaccinations offer a glimmer of hope, the rising death toll and new variants continue to dominate the current scenario.As we begin to understand more about SARS-CoV-2 infections, the territory of reinfections with COVID-19 remains unexplored.In emtek 2113 this review, we will discuss several aspects of reinfection: (a) How is COVID-19 reinfection characterized? (b) Does prior literature differentiate between reinfection and reactivation? (c) What SARS-CoV-2 strains do the vaccines target and can they protect against new strains? Larger and longer timeline studies are needed to understand reinfection risks.

With the ongoing distribution of the SARS-CoV-2 vaccines to provide protection, the understanding of the possibility for SARS-CoV-2 reinfection remains critical.Abbreviations click here CDC: Centers for Disease ControlSARS-CoV-2: Severe acute respiratory syndrome coronavirus 2COVID-19: Coronavirus disease 2019RT-PCR: Reverse Transcription Polymerase Chain ReactionPASC: Post-Acute Sequelae of SARS-CoV-2 infection.